Utility of iliac crest tetracycline-labelled bone biopsy in osteoporosis and metabolic bone disease: An evaluation of 95 cases over a period of 25 years

Utility of iliac crest tetracycline-labelled bone biopsy in osteoporosis and metabolic bone disease: An evaluation of 95 cases over a period of 25 years

Background: Metabolic bone diseases (MBD) are typically diagnosed by non-invasive imaging and clinical biomarkers. However, imaging does not provide structural information, and biomarkers can be transiently affected by many systemic factors. Bone biopsy and pathologic evaluation is the gold standard...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Juan M. Colazo, Julia Quirion, Anthony D. Judice, Jennifer Halpern, Herbert S. Schwartz, S. Bobo Tanner, Joshua M. Lawrenz, Kathryn M. Dahir, Ginger E. Holt
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Elsevier 2023-12-01
Ráidu:Bone Reports
Fáttát:
Metabolic bone disease
Osteoporosis
Osteomalacia
Bone biopsy
Antibiotic-labelled bone biopsy
Tetracycline labelling
Liŋkkat:http://www.sciencedirect.com/science/article/pii/S2352187223000633

Interneahtta

http://www.sciencedirect.com/science/article/pii/S2352187223000633

Geahča maid